7182617
Emerin, Mouse anti-Human, Clone: EMD/2167, Novus Biologicals™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Emerin
Concentration
0.2 mg/mL
Applications
Western Blot, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Peptide Array
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human
Gene Accession No.
P50402
Gene ID (Entrez)
2010
Immunogen
Recombinant human Emerin protein fragment (around aa 56-167) (exact sequence is proprietary)
Primary or Secondary
Primary
Content And Storage
Store at 4°C.
Clone
EMD/2167
Dilution
Western Blot 1-2 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunocytochemistry/Immunofluorescence 1-3 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
10 mM PBS with 0.05% BSA
Gene Alias
emerin, Emery-Dreifuss muscular dystrophy, LEM domain containing 5, STAEDMDLEMD5
Gene Symbols
EMD
Isotype
IgG1 κ
Purification Method
Protein A or G purified
Test Specificity
Emerin is a member of the nuclear lamina associated protein family. It is ubiquitously expressed and localized to the nuclear membrane in normal cells. Mutations of the gene that encodes emerin result in the X-linked recessive disease Emery-Dreifuss muscular dystrophy (EDMD), which is characterized by slowly progressing contractures, skeletal muscle wasting and cardiomyopathy. Reportedly, lack of Emerin expression is one cause of EDMD. Emerin is involved in the association of the nuclear membrane with the lamina, and is localized specifically to desmosomes and fasciae adherents in the heart. Identification of nuclear membrane irregularities with anti-emerin antibody has been reported useful in diagnosing papillary thyroid carcinoma.
Related Products
Description
- Emerin Monoclonal specifically detects Emerin in Human samples
- It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Protein Array.
Compare Similar Items
Show Difference
Antigen: Emerin
Concentration: 0.2 mg/mL
Applications: Western Blot, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Peptide Array
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P50402
Gene ID (Entrez): 2010
Immunogen: Recombinant human Emerin protein fragment (around aa 56-167) (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: Store at 4°C.
Clone: EMD/2167
Dilution: Western Blot 1-2 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunocytochemistry/Immunofluorescence 1-3 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: 10 mM PBS with 0.05% BSA
Gene Alias: emerin, Emery-Dreifuss muscular dystrophy, LEM domain containing 5, STAEDMDLEMD5
Gene Symbols: EMD
Isotype: IgG1 κ
Purification Method: Protein A or G purified
Test Specificity: Emerin is a member of the nuclear lamina associated protein family. It is ubiquitously expressed and localized to the nuclear membrane in normal cells. Mutations of the gene that encodes emerin result in the X-linked recessive disease Emery-Dreifuss muscular dystrophy (EDMD), which is characterized by slowly progressing contractures, skeletal muscle wasting and cardiomyopathy. Reportedly, lack of Emerin expression is one cause of EDMD. Emerin is involved in the association of the nuclear membrane with the lamina, and is localized specifically to desmosomes and fasciae adherents in the heart. Identification of nuclear membrane irregularities with anti-emerin antibody has been reported useful in diagnosing papillary thyroid carcinoma.
Antigen:
Emerin
Concentration:
0.2 mg/mL
Applications:
Western Blot, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Peptide Array
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P50402
Gene ID (Entrez):
2010
Immunogen:
Recombinant human Emerin protein fragment (around aa 56-167) (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
Store at 4°C.
Clone:
EMD/2167
Dilution:
Western Blot 1-2 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunocytochemistry/Immunofluorescence 1-3 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
10 mM PBS with 0.05% BSA
Gene Alias:
emerin, Emery-Dreifuss muscular dystrophy, LEM domain containing 5, STAEDMDLEMD5
Gene Symbols:
EMD
Isotype:
IgG1 κ
Purification Method:
Protein A or G purified
Test Specificity:
Emerin is a member of the nuclear lamina associated protein family. It is ubiquitously expressed and localized to the nuclear membrane in normal cells. Mutations of the gene that encodes emerin result in the X-linked recessive disease Emery-Dreifuss muscular dystrophy (EDMD), which is characterized by slowly progressing contractures, skeletal muscle wasting and cardiomyopathy. Reportedly, lack of Emerin expression is one cause of EDMD. Emerin is involved in the association of the nuclear membrane with the lamina, and is localized specifically to desmosomes and fasciae adherents in the heart. Identification of nuclear membrane irregularities with anti-emerin antibody has been reported useful in diagnosing papillary thyroid carcinoma.
Antigen: C1QB
Concentration: 0.2 mg/mL
Applications: Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P02746
Gene ID (Entrez): 713
Immunogen: Recombinant fragment (around aa 41-188) of human C1QB protein (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: Store at 4°C.
Clone: C1QB/2965
Dilution: Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: 10 mM PBS with 0.05% BSA
Gene Alias: B chain, complement C1q subcomponent subunit B, complement component 1, q subcomponent, B chain, complement subcomponent C1q chain B, q subcomponent, beta polypeptide
Gene Symbols: C1QB
Isotype: IgG1 κ
Purification Method: Protein A or G purified
Test Specificity: __
Antigen:
C1QB
Concentration:
0.2 mg/mL
Applications:
Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P02746
Gene ID (Entrez):
713
Immunogen:
Recombinant fragment (around aa 41-188) of human C1QB protein (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
Store at 4°C.
Clone:
C1QB/2965
Dilution:
Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
10 mM PBS with 0.05% BSA
Gene Alias:
B chain, complement C1q subcomponent subunit B, complement component 1, q subcomponent, B chain, complement subcomponent C1q chain B, q subcomponent, beta polypeptide
Gene Symbols:
C1QB
Isotype:
IgG1 κ
Purification Method:
Protein A or G purified
Test Specificity:
__
Antigen: TRAF-1
Concentration: 0.2 mg/mL
Applications: Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q13077, Q13077
Gene ID (Entrez): 7185
Immunogen: Recombinant fragment of human TRAF-1 protein (around aa 73-219) (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: Store at 4°C.
Clone: TRAF1/2770
Dilution: Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: 10 mM PBS with 0.05% BSA
Gene Alias: EBI6MGC:10353, Epstein-Bar virus-induced protein 6, Epstein-Barr virus-induced protein 6, TNF receptor-associated factor 1
Gene Symbols: TRAF1
Isotype: IgG1 κ
Purification Method: Protein A or G purified
Test Specificity: This monoclonal antibody recognizes a protein of 52kDa, which is identified as TRAF-1 (TNFR-associated factor 1), which is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations. CD30-positive lymphoproliferations of the skin comprise 30% of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL).
Antigen:
TRAF-1
Concentration:
0.2 mg/mL
Applications:
Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q13077, Q13077
Gene ID (Entrez):
7185
Immunogen:
Recombinant fragment of human TRAF-1 protein (around aa 73-219) (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
Store at 4°C.
Clone:
TRAF1/2770
Dilution:
Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
10 mM PBS with 0.05% BSA
Gene Alias:
EBI6MGC:10353, Epstein-Bar virus-induced protein 6, Epstein-Barr virus-induced protein 6, TNF receptor-associated factor 1
Gene Symbols:
TRAF1
Isotype:
IgG1 κ
Purification Method:
Protein A or G purified
Test Specificity:
This monoclonal antibody recognizes a protein of 52kDa, which is identified as TRAF-1 (TNFR-associated factor 1), which is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations. CD30-positive lymphoproliferations of the skin comprise 30% of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL).
Antigen: TRAF-1
Concentration: 0.2 mg/mL
Applications: Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q13077, Q13077
Gene ID (Entrez): 7185
Immunogen: Recombinant fragment of human TRAF-1 protein (around aa 73-219) (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: Store at 4°C.
Clone: TRAF1/3298
Dilution: Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: 10 mM PBS with 0.05% BSA
Gene Alias: EBI6MGC:10353, Epstein-Bar virus-induced protein 6, Epstein-Barr virus-induced protein 6, TNF receptor-associated factor 1
Gene Symbols: TRAF1
Isotype: IgG2b κ
Purification Method: Protein A or G purified
Test Specificity: This monoclonal antibody recognizes a protein of 52kDa, which is identified as TRAF-1 (TNFR-associated factor 1), which is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations. CD30-positive lymphoproliferations of the skin comprise 30% of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL).
Antigen:
TRAF-1
Concentration:
0.2 mg/mL
Applications:
Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q13077, Q13077
Gene ID (Entrez):
7185
Immunogen:
Recombinant fragment of human TRAF-1 protein (around aa 73-219) (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
Store at 4°C.
Clone:
TRAF1/3298
Dilution:
Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
10 mM PBS with 0.05% BSA
Gene Alias:
EBI6MGC:10353, Epstein-Bar virus-induced protein 6, Epstein-Barr virus-induced protein 6, TNF receptor-associated factor 1
Gene Symbols:
TRAF1
Isotype:
IgG2b κ
Purification Method:
Protein A or G purified
Test Specificity:
This monoclonal antibody recognizes a protein of 52kDa, which is identified as TRAF-1 (TNFR-associated factor 1), which is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations. CD30-positive lymphoproliferations of the skin comprise 30% of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL).